Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Direct Detection of Legionella Species from Bronchoalveolar Lavage and Open Lung Biopsy Specimens: Comparison of LightCycler PCR, In Situ Hybridization, Direct Fluorescence Antigen Detection, and Culture

R. T. Hayden, J. R. Uhl, X. Qian, M. K. Hopkins, M. C. Aubry, A. H. Limper, R. V. Lloyd, F. R. Cockerill
R. T. Hayden
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. R. Uhl
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
X. Qian
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. K. Hopkins
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. C. Aubry
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. H. Limper
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. V. Lloyd
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. R. Cockerill
Mayo Clinic, Rochester, Minnesota
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.39.7.2618-2626.2001
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We developed a rapid thermocycling, real-time detection (also known as real-time PCR) method for the detection of Legionellaspecies directly from clinical specimens. This method uses the LightCycler (Roche Molecular Biochemicals, Indianapolis, Ind.) and requires approximately 1 to 2 h to perform. Both aLegionella genus PCR assay and Legionella pneumophila species-specific PCR assay were designed. A total of 43 archived specimens from 35 patients were evaluated, including 19 bronchoalveolar lavage (BAL) specimens and 24 formalin-fixed, paraffin-embedded open lung biopsy specimens. Twenty-five of the specimens were culture-positive for Legionella (9 BAL specimens and 16 tissue specimens). BAL specimens were tested by LightCycler PCR (LC-PCR) methods and by a direct fluorescent antibody (DFA) assay, which detects L. pneumophila serogroups 1 to 6 and several other Legionella species. Tissue sections were tested by the two LC-PCR methods, by DFA, by an in situ hybridization (ISH) assay, specifically designed to detect L. pneumophila, and by Warthin-Starry (WS) staining. The results were compared to the “gold standard” method of bacterial culture. With BAL specimens the following assays yielded the indicated sensitivities and specificities, respectively: Legionella genus detection byLegionella genus LC-PCR, 100 and 100%;Legionella genus detection by DFA assay, 33 and 100%; andL. pneumophila detection by L. pneumophilaspecies-specific LC-PCR, 100 and 100%. With open lung biopsy specimens the following assays yielded the indicated sensitivities and specificities, respectively: Legionella genus detection by LC-PCR 68.8 and 100%; Legionella genus detection by DFA assay, 44 and 100%; Legionella genus detection by WS staining, 63 and 100%; L. pneumophila species-specific detection by LC-PCR, 17 and 100%; and L. pneumophilaspecies-specific detection by ISH, 100 and 100%. The analytical sensitivity of both LC-PCR assays was <10 CFU/reaction. LC-PCR is a reliable method for the direct detection of Legionellaspecies from BAL specimens. The Legionella genus LC-PCR assay could be performed initially; if positive, L. pneumophila species-specific LC-PCR could then be performed (if species differentiation is desired). The speed with which the LC-PCR procedure can be performed offers significant advantages over both culture-based methods and conventional PCR techniques. In contrast, for the methods evaluated, culture was the best for detecting multipleLegionella species in lung tissue. WS staining,Legionella genus LC-PCR, and L. pneumophilaspecies-specific ISH were useful as rapid tests with lung tissue.

The genus Legionella, family Legionellaceae, includes over 40 different species of fastidious gram-negative bacilli, with over 60 described serogroups (2, 21, 41, 60). While these organisms represent normal environmental flora, many have been shown to cause human disease, most commonly opportunistic pneumonia in immunocompromised patients. The vast majority of such cases (approximately 85%) are due to L. pneumophila, with a substantial minority due to other species, most commonly L. micdadei, L. bozemanii, L. dumoffii, andL. longbeachae (17, 41, 47).Legionella pneumonia can be community acquired or nosocomial and sporadic or epidemic in nature. Pulmonary infection may be subclinical or severe and life threatening. The fatality rate can approach 50% in immunocompromised patients (60). The organism often responds to antimicrobial therapy, usually with macrolides, and clinical responses usually occur within 3 to 5 days. The latter fact, combined with clinical and radiographic features that are often nonspecific, serves to underscore the value of a prompt and accurate laboratory diagnosis.

The diagnosis of Legionella infection can be made from a number of specimen types and by a number of testing modalities. Bacterial culture of bronchoscopy or lung biopsy specimens remains the most sensitive means of detection (7, 11, 61). Specialized growth medium, such as buffered charcoal-yeast extract agar (BCYEα), is required, with up to 2 weeks of incubation recommended to ensure maximal recovery (11). Isolates are typically identified by a combination of colony and Gram stain morphology, with serologic confirmation and species identification, using specific fluorescein-labeled antibodies. Direct detection of organisms in uncultured clinical specimens, usually performed with immunofluorescent methods, is much more rapid than culture, but the sensitivity of these methods has been reported to be poor (11, 12, 56). A variety of means, including radioimmunoassay, enzyme immunoassay, and latex agglutination, can be used to detect a soluble polysaccharide antigen of L. pneumophila (serogroup 1 only), in urine, with a reported sensitivity of 55 to 90% (8-10, 25, 48, 56). Serologic methods are highly sensitive (56, 60), but their utility is generally limited to epidemiologic studies, due to the time lag needed to detect seroconversion. A number of methods have been used in attempt to identify these organisms in paraffin-embedded tissue sections, including various histochemical and immunohistochemical techniques (3-5, 50, 52). Silver impregnation stains, such as the Warthin-Starry (WS) stain (39), serve as the current mainstay of detection in such cases.

Assays based on molecular diagnostic techniques have included DNA probes for in situ hybridization (ISH), as well as PCR-based methods. Probes have largely been directed against rRNA sequences, with sensitivities of approximately 30 to 75% in both bronchoalveolar lavage (BAL) and fixed tissue specimens (11, 13, 14, 16, 18, 19, 45, 55). PCR methodology has been used primarily against the 5S and 16S rRNA genes and against the macrophage infectivity potentiator (mip) gene of L. pneumophila. The latter amplification assays have been utilized for detection ofLegionella species in environmental specimens, serum, urine, throat swabs, and BAL specimens (1, 6, 22, 24, 27, 28, 32, 33, 35-38, 40, 42, 46, 49, 53). Several studies have shown 100% sensitivity when such methods are used on BAL specimens. A few investigators have suggested that PCR may exceed culture in its ability to detect Legionella in these specimens (6, 22, 24, 33). To our knowledge, no studies exist that examine the sensitivity of these techniques in tissue specimens.

Conventional molecular methods, used in the above-noted studies, require PCR-based amplification, followed by probe hybridization detection (24). These methods are labor intensive and frequently require at least 1 day to perform. Additionally, the required manipulation of postamplification products increases the risk of carryover contamination and resultant false positivity.

By using commercially available, rapid cycle, real-time PCR instrumentation (LightCycler; Roche Molecular Biochemicals, Indianapolis, Ind.), PCR amplification and detection can be combined in a single closed cuvette, with dramatically reduced cycling time (58). This method obviates the need for further manipulation of the specimen, greatly reduces turnaround time, and diminishes the risk of cross-contamination between samples (54, 57). As recently demonstrated (15, 26, 31, 44, 59), this and other real-time PCR methods are attractive alternatives to conventional PCR techniques in the clinical laboratory.

We describe the development of a real-time LightCycler PCR (LC-PCR) method, for the detection of Legionella species directly from clinical specimens. Both a Legionella genus LC-PCR assay and an L. pneumophila species-specific LC-PCR assay were designed. With conventional culture serving as the “gold standard,” the results of LC-PCR were compared to direct fluorescent antibody (DFA) assay for the detection of Legionella species in BAL specimens, and to DFA assay, ISH, and WS staining for the detection of Legionella species in open lung biopsy specimens.

MATERIALS AND METHODS

Control organisms.All experiments to optimize PCR conditions, as well as dilution studies to evaluate sensitivity and plasmid construction, were performed using L. pneumophilaserogroup 1 (ATCC 33152). Other strains of Legionella, used for validation of the assay, are listed in Table1, and included L. pneumophilaserogroups 1 to 6, as well as several other strains ofLegionella, representing the most commonly isolated non-L. pneumophila species. The specificity of the assay was assessed using a panel of control strains of bacteria (Table2), representing both commonly isolated respiratory pathogens and nonpathogens that might be detected in respiratory specimens.

View this table:
  • View inline
  • View popup
Table 1.

Control strains of Legionella

View this table:
  • View inline
  • View popup
Table 2.

Specificity panel for Legionella LCR-PCR assays

Clinical specimens.A retrospective review of positiveLegionella culture results at the Mayo Clinic, from 1979 to 1999, revealed nine BAL specimens for which frozen, archived material was available. In seven of these cases, frozen cell suspensions were available; in two cases, only supernatant was available for analysis. In addition, cell suspensions from 10 BAL specimens which were culture-negative for Legionella, were randomly selected from similarly archived material. These cell suspensions were originally prepared from BAL specimens using a cytospin method. Only cell suspensions having >2 × 106 cells counted by microscopy on a 4-mm2 grid were cultured forLegionella spp. and archived. Cultures of BAL or lung biopsy specimens were performed at the time the specimens were collected using standard techniques (43); cultures were not repeated on archived portions of these specimens during the present study. In all cases, archived results of DFA assays for Legionella, performed on fresh specimens, were also available. A retrospective review, also from 1979 to 1999, revealed nine open lung biopsy specimens culture positive for Legionella species, for which a total of 16 formalin-fixed, paraffin-embedded tissue blocks were available for evaluation. Eight open lung biopsy specimens, from the same time period, all showing nonspecific histologic findings of pneumonia or pneumonitis and all culture-negative forLegionella species, were also selected for evaluation. A single tissue block was used from each of these culture-negative cases.

BAL processing and culture methodology.Prior to culture, BAL specimens were centrifuged for 15 min at 1,200 × gand 2,500 rpm, and the top 7.5 ml of the resulting suspension was removed. The remaining cell concentrate was mixed and used for culture. Fresh tissue from open lung biopsy specimens was homogenized in enriched brain heart infusion broth (Difco formulation; Becton Dickinson, Sparks, Md.) prior to plating. Culture forLegionella species was performed on BCYEα and BCYEα with polymyxin B, anisomycin, and vancomycin (Becton Dickinson), and plates were incubated at 35°C, in room air, for up to 14 days. Organisms from characteristic colonies were Gram stained and identified to the species level using a commercially available panel of fluorescein isothiacyanate (FITC)-labeled antibodies (SciMedX, Denville, N.J.).

Histopathologic examination.Tissues stained with hematoxylin and eosin and WS stain were cut and stained concurrent with and consecutive to sections taken for ISH, DFA assay, and PCR. All tissue sections were cut at 4 μm. Hematoxylin and eosin staining and WS staining were carried out using standard histologic laboratory methods (39).

The WS-stained slides were evaluated in a blinded manner by one of the authors (M.C.A.) Slides positive for Legionella-like organisms showed dark-brown-staining bacillary structures (Fig.1).

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Legionella bacilli, demonstrated by WS staining (left) and by ISH (right).

DFA detection.Prior to direct examination, fresh BAL specimen was centrifuged for 5 min, at 2,500 rpm, and the resultant supernatant was removed (in some cases this supernatant was later used in the PCR assay; see below, under “Real-time PCR”). The cell pellet was resuspended in normal saline, with lysis agent and/or mucolytic agents added as necessary. This cell suspension was used both for DFA assay and PCR (see below). For each smear to be examined by DFA, 200 μl was cytocentrifuged at 700 rpm, for 7 min, onto a clean glass slide and allowed to air dry. Histologic sections were deparaffinized through xylene and graded ethanol dilutions and allowed to air dry prior to examination. DFA assay was performed per the manufacturer's instructions (SciMedX). Two polyvalent FITC-labeled rabbit anti-Legionella conjugate pools were applied to a separate replicate smear or tissue section. FITC-labeled negative rabbit globulin was applied to a third replicate of the specimen, to serve as a negative control. Antibody pools were also applied to a positive control slide prepared from a knownLegionella-positive lung tissue specimen in formalin. Positives were interpreted based on the presence of fluorescent bacillary structures in a given smear or section.

ISH.ISH was performed by a procedure, as previously described with some modifications (34).

(i) Oligonucleotide probes.Two oligonucleotide probes (Table 3), both directed against the 16S rRNA sequence of L. pneumophila, were used. One probe was previously described (19). The other probe was designed based on the analysis of sequence matches and mismatches (GenBank). The specificity of probes was checked against the sequences of other bacteria, fungi, parasites, and animals, using Genetics Computer Group software (Madison, Wis.). Probes were 3′ tailed with digoxigenin-11-dUTP (Enzo Diagnostic, Inc.) and then diluted to a final concentration of 2.0 ng/μl in hybridization buffer.

View this table:
  • View inline
  • View popup
Table 3.

Nucleic acid targets for primers and probes

(ii) Pretreatment of sections for ISH.Paraffin sections, after deparaffinizing and rehydration, were rinsed twice in diethyl pyrocarbonate-treated H2O for 2 min each. Endogenous alkaline phosphatase activity was quenched with 0.2 M HCl for 20 min at room temperature, and slides were microwaved for 10 min in 10 mM citric acid, pH 6.0, and cooled to room temperature. Sections were then digested with proteinase K (25 μg/ml; Sigma, St. Louis, Mo.) in 10 mM phosphate-buffered saline, pH 7.2, for 10 min at room temperature, followed by acetylation for 15 min with freshly prepared 0.6% acetic anhydride in 0.1 M triethanolamine (pH 8.0). Prehybridization was performed for 30 min, at room temperature, with a mixture containing 50% deionized formamide (Sigma), 10% dextran sulfate (Sigma), 1× Denhardt's solution (Sigma), 3× standard saline citrate (SSC), salmon sperm DNA (100 μg/ml, Sigma), yeast tRNA (125 μg/ml), polyadenylic-cytidylic acid (10 μg/ml), Tris (0.05 M), EDTA (5 mM), 600 mM NaCl, and 0.1% sodium pyrophosphate (inorganic).

(iii) Hybridization and post hybridization washes.Following prehybridization, residual prehybridization buffer was thoroughly removed from around the tissue section. An oligonucleotide probe cocktail specific for L. pneumophila (2 ng/μl in prehybridization buffer) was applied to sections. A Sigmacote (Sigma) coverglass was placed on each slide, and the slides were heat treated at 95°C for 5 min and hybridized in a humid environment for 3 h at 50°C. Sections were rinsed twice in 2× SSC for 10 min at room temperature, washed in 0.5× SSC at 37°C for 20 min (to remove excess probe), and rinsed twice in buffer A (1% normal sheep serum in 0.3% Triton X-100) for 2 min at room temperature.

(iv) Immunochemical detection.After posthybridization washing, digoxigenin-labeled probes were detected according to the manufacturer's instructions (digoxigenin detection kit; Boehringer Mannheim). Briefly, after preincubation of sections for 30 min in blocking buffer A (1% normal swine serum and 0.3% Triton X-100), the sections were incubated in a 1:200 dilution of alkaline phosphatase-conjugated antidigoxigenin Fab fragment in blocking buffer A for 1 h at room temperature. Rinsing with buffer A and buffer C (Tris-HCl and MgCl, pH 9.5) was performed, and sections were subsequently reacted with nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyphosphate (BCIP), forming an insoluble blue precipitate at the site of reaction. Sections were then rinsed in buffer C, counterstained with 0.1% nuclear fast red, rinsed again in buffer C, dehydrated in graded ethanols, and cleared in xylene, and a coverslip was placed on each section with a xylene-based synthetic mounting medium. Positive interpretation of a slide was based on the presence of blue-staining bacillary structures, against a pink-red background (Fig. 1).

(v) ISH negative controls and probe specificity tests.Negative controls used for ISH consisted of (i) omission of the probes from the hybridization reaction; (ii) slides hybridized with nonlabeled probe; (iii) cross-reactivity testing for target specificity, using an ISH probe for albumin, hybridized to Legionella-positive tissue sections; and (iv) cross-reactivity testing for probe specificity, using five additional specimens with tissue involvement by other gram-positive and gram-negative bacteria.

Real-time PCR.PCR and product detection were performed simultaneously on LightCycler instrumentation (Roche Molecular Biochemicals). The LightCycler is a combined thermocycler and fluorimeter that offers rapid PCR thermocycling (20 to 40 min). The temperature is controlled with circulated heated and ambient air. Samples and PCR master mix are contained in 30-μl glass cuvettes (58). Sample detection is based on the principle of fluorescence resonance energy transfer (57, 58), with adjacent hybridization probes directed against the intended PCR product. With fluorescein serving as the donor fluorophore and LC-Red 640 (Roche Molecular Biochemicals) serving as the acceptor fluorophore, the presence of PCR amplicons can be assessed by detection of LC-Red 640 fluorescence. Samples can be assayed for the presence of this signal during each PCR cycle, and the cycle number at which the signal is first detected can be correlated to the original concentration of target. The specificity of amplification can be confirmed by melting curve analysis. Single melting peaks can be generated by depicting the negative derivative of fluorescence versus temperature (−dF/dT) over the course of a gradual PCR product melt (see below, “PCR cycling and melting curve conditions”).

(i) Extraction of control bacterial strains.Pure culture isolates, used as control organisms, were extracted by two different methods. (i) In the case of gram-negative isolates, includingLegionella species, bacterial colonies were suspended in sterile H2O, to a turbidity of approximately 1 McFarland standard, lysed in a 100°C heat block for 10 min, and centrifuged for 1 min at 20,000 × g . The resulting supernatant was used for analysis. (ii) In the case of gram-positive isolates, bacterial colonies were suspended in 1.0 ml of 1 N NaOH, to a turbidity of approximately 1 McFarland standard and incubated at room temperature for 5 min. The cells were pelleted, washed in an equal volume of 0.5 M Tris-HCl (pH 8.0), pelleted again, and resuspended in 100 μl of H2O. After heating in a 100°C heat block for 10 min, the suspension was centrifuged for 1 min at 20,000 × g , and the supernatant was used for analysis. Control extracts were used at a final dilution of 1:100 in sterile H2O. The presence of amplifiable DNA in specificity controls was verified by utilizing broad-range 16S ribosomal (rDNA) amplification by standard methods (23). Specific PCR assays were used to verify the presence of nucleic acid in extracts of mycobacteria and chlamydiae.

(ii) Extraction of BAL specimens.BAL specimens were extracted using Chelex 100 (InstaGene Matrix; Bio-Rad Laboratories, Hercules, Calif.). Briefly, the specimen was mixed thoroughly, and 20 μl was added to 200 μl of InstaGene matrix. The resulting solution was mixed and placed in a 100°C heat block for 10 min. After mixing again, the sample was centrifuged for 2 min at 12,000 rpm. The resulting supernatant was used for analysis.

(iii) Extraction of tissue specimens.Tissue sections (25 μm thick) were cut consecutively with other sections that were used for DFA and ISH assays. The sections were each cut with a clean blade and placed in a sterile glass tube. Sections were deparaffinized in xylene, washed twice in absolute ethanol, subjected to proteinase K digestion overnight at 55°C, and then placed in a 100°C heat block for 15 min. Extractions were carried out using QIAmp DNA spin columns (Qiagen Inc., Valencia, Calif.), following a standard protocol. DNA was eluted from the spin columns twice, each using 50 μl of elution buffer AE (from the QIAmp DNA mini kit). Elution buffer was incubated in the column for 1 min at room temperature, prior to the first elution, and for 5 min at RT prior to the second elution. The first and second eluants were analyzed separately by PCR.

(iv) Primers and probes.All nucleic acid targets for primers and probes used in the study are listed in Table 3. Amplicons were kept to a minimum length (105 bp for the 5S gene and 124 bp formip) in order to enhance the utility of these assays in formalin-fixed tissue. Probes were constructed in order to juxtapose donor (fluorescein) and acceptor (LC-Red 640) fluorophore dyes, when probes were annealed to amplicon. The mip primer-probe set was constructed for specific detection of L. pneumophila(Legionella pneumophila species-specific LC-PCR). The 5S rRNA primer-probe set was constructed to allow detection of all commonLegionella species (Legionella genus LC-PCR). Primers for the latter assay were slightly truncated versions of the 20-mer sequences, L5SL9 and L5SR93, previously reported by Mahbubani et al. (35). Due to constraints imposed by the size and sequence of the 5S amplicon, only a single probe, a 23-bp portion of the 50-mer probe, also reported by Mahbubani et al. (35) was used. This probe was labeled at its 5′ end with LC-Red 640, while the fluorescein label was placed near the 3′ end of the reverse primer, for fluorescence resonance energy transfer signal production.

(v) PCR master mix (5S).A 5-μl aliquot of sample (5 μl of H2O was used as a negative control for each run) was added to 15 μl of PCR mix in each sample cuvette. Optimized PCR master mix consisted of 50 mM KCl–20 mM Tris-HCl (pH 8.4) with a 0.1 mM concentration of each of the deoxyribonucleoside triphosphates, 6 mM MgCl2, a 0.5 μM concentration of both 5S primers, a 0.1 μM concentration of the single 5S probe, 0.05% IGEPAL CA-630 (Sigma), 0.025% bovine serum albumin, and 0.025 U of PLATINUM Taq DNA Polymerase (Life Technologies, Rockville, Md.) per μl.

(vi) PCR Master Mix(mip).A 5-μl aliquot of sample (5 μl of H2O was used as a negative control for each run) was added to 15 μl of PCR mix in each sample cuvette. Optimized master mix consisted of 50 mM KCl–20 mM Tris-HCl (pH 8.4) with a 0.2 mM concentration of each of the deoxyribonucleoside triphosphates, 6 mM MgCl2, a 0.5 μM concentration of both mipprimers, a 0.2 μM concentration of the fluorescein mipprobe, a 0.4 μM concentration of the LC-Red 640 mip probe, 0.05% IGEPAL CA-630 (Sigma), 0.025% bovine serum albumin, and 0.025 U of PLATINUM Taq DNA Polymerase (Life Technologies) per μl.

(vii) PCR cycling and melting curve conditions.PCR reagents and specimen extracts were sealed in glass capillary cuvettes with plastic plugs, centrifuged to allow mixing and to drive the mix into the distal end of each tube, and then placed on the LightCycler instrument. The cycling protocol was identical for both themip and the 5S amplification reactions: one cycle of 95°C for 2 min followed by 50 cycles of denaturation at 95°C, annealing for 10 s at 57°C, and extension for 5 s at 72°C. Melting curves were generated as follows: starting at 55°C, the thermal chamber temperature was slowly raised to 85°C, during which time fluorescence was measured at frequent intervals. Analysis of PCR amplification and melting curves was carried out using LightCycler software.

(viii) Sensitivity and inhibition studies.The sensitivities of both PCR assays were assessed by testing serial dilutions of a known number of CFU of L. pneumophila. PCR inhibition was assessed by spiking all culture- and PCR-negative eluants of both BAL and tissue specimens with low concentrations of L. pneumophila. Concentrations of organism used were within 1 log unit of each assay's limit of sensitivity. Inhibition was demonstrated by loss of amplification signal and/or by appearance of signal at a later cycle number than that seen in similar concentrations of organisms, diluted in sterile water as a control.

Analysis of results.For direct (WS, DFA, ISH) assays, positives were defined by the presence of five or more identifiable bacilli, with the proper staining characteristics for the given assay (as defined above). For PCR, positives were defined by a fluorescent signal from the reporter dye (either during PCR amplification or during melting curve analysis) of three times the baseline level of fluorescence (in turn defined by the signal from the negative control cuvette for each run). The results of culture were considered to be the gold standard against which all other assays were compared. Several tissue isolates were originally designated “Legionnaires' disease bacillus” (LDB), as they were recovered before methods were in use for species determination. These were all retrospectively classified asL. pneumophila, based on the results of ISH, for the current study. Analysis of results was based on the number of specimens, rather than on the number of cases or patients tested. For BAL fluid samples, cells and supernatants from a single lavage procedure were classified as a single specimen. A breakdown of results, by case, as well as by specimen, is given in Tables 4 and5.

View this table:
  • View inline
  • View popup
Table 4.

Comparison of results for BAL specimens

View this table:
  • View inline
  • View popup
Table 5.

Comparison of results for open lung biopsy specimens

RESULTS

Validation of PCR assay on culture isolates.BothLegionella primer-probe sets were tested against a total of 17 different known strains of Legionella (Table 1). AllLegionella species and strains were detected by theLegionella genus (5S rDNA) primers and probes, with allL. pneumophila serotypes detected by the L. pneumophila species-specific (mip) primers and probes. Both PCR assays showed 100% specificity (Table 2), with no evidence of cross-reactivity against any of the non-Legionella isolates. Both tests showed an analytic sensitivity of <10 CFU when used with serial dilutions of a known concentration of control organism.

BAL specimens.As shown in Tables 4 and6, the 5S rDNA Legionellagenus LC-PCR assay detected nine of nine culture-positive specimens (100% clinical sensitivity), including two non-L. pneumophila species (L. bozemanii and L. micdadei). All 10 culture-negative specimens were negative by this LC-PCR assay (10 of 10; 100% specificity). Similarly, the mip L. pneumophila species-specific PCR assay detected seven of sevenL. pneumophila culture-positive specimens and 12 of 12 specimens were correctly identified as negative for L. pneumophila (100% clinical sensitivity and specificity). Inhibition studies showed minimal evidence of inhibitory effect for each of the 10 Legionella-negative extracts, based on the ability to detect low concentrations of spiked organisms. Results of inhibition assays were similar for both the 5S rRNALegionella genus and the L. pneumophilaspecies-specific tests. Only three of nineLegionella-culture-positive specimens were detected by DFA assay (33% sensitivity and 100% specificity).

View this table:
  • View inline
  • View popup
Table 6.

Sensitivities and specificities of all assays evaluated

Open lung biopsy specimens.Tables 5 and 6 show the results obtained from open lung biopsy specimens. The method used most commonly by surgical pathologists, examination of WS-stained slides, showed positive results in 10 of 16 specimens which were culture-positive forLegionella species (63% sensitivity); there were no false-positive stains (100% specificity). The sensitivity and specificity for the DFA method were 44% (7 of 16 culture-positive specimens detected) and 100%, respectively. ISH detected all 14L. pneumophila culture-positive specimens (100% sensitivity and 100% specificity). As noted previously, the ISH assay was not designed for detection of non-L. pneumophila species; therefore, the slides with L. bozemanii were counted as culture negative for the purposes of this analysis. Specificity controls (see Materials and Methods)—including specimens which were culture-negative for Legionella, probe-negative assays, assays performed with nonlabeled probe, and both target and probe cross-reactivity assays—were all negative.

PCR was performed separately on the first and second 50-μl eluants from the extraction columns (see Materials and Methods). Table 4 shows the results of these two eluants separately and in aggregate for each case. In all, 11 of 16 tissue specimens tested positive forLegionella (69% clinical sensitivity), using theLegionella genus (5S rDNA) primer-probe set. Although not uniformly advantageous, the second eluant showed a higher rate of positivity (nine slides positive) than the first eluant (six slides positive). The L. pneumophila species-specific assay (mip) was much less sensitive, being positive in only 2 of 14 cases (17% clinical sensitivity). Inhibition assays, performed with the extracts of culture-negative specimens, showed similar results for both the Legionella genus and the L. pneumophilaspecies-specific assays. There was minimal inhibition by the second eluants of all extracts. In contrast, the first eluants showed variable, but in some cases marked, inhibition.

Turnaround time. Legionella culture, while usually positive in 3 to 5 days, is not reported as negative by our laboratory until a full 2-week incubation period has elapsed. DFA assay of BAL specimens, including BAL prep and cytospin, in our hands requires 1 to 2 h. Similarly, real-time PCR of BAL specimens requires approximately 1 to 2 h, including sample preparation, cycling, and detection. Studies performed on fixed tissue sections require more time, due to the need for overnight tissue processing and paraffin embedding. Including that processing time, WS, DFA, and ISH assays of tissue all require ∼24 h for assay turnaround. LC-PCR of tissue required an additional overnight digestion, bringing its reporting time to 2 days.

DISCUSSION

For many years the gold standard test for diagnosingLegionella infection has been culture. A drawback of culture is that results may not be available for several days. Rapid testing methods, which include direct histochemical staining of tissue, fluorescent antibody staining of tissue or pulmonary secretions, urine antigen detection, and serology, have been useful but often lack sensitivity and/or specificity. Recently, real-time PCR assays have become available which are highly sensitive and can be performed in as little as 1 to 2 h. In the present study, we evaluated the utility of the LC-PCR method for detecting Legionella species in pulmonary tissues and in BAL fluid. We compared this method, along with DFA assay, ISH, and WS staining, to the gold standard culture method.

With BAL specimens, LC-PCR showed a high degree of sensitivity and specificity. These results agree with previous publications, which used conventional nucleic acid amplification methods (22, 24, 28, 29, 53). By using the combination of both 5S rDNA- andmip-directed primer-probe sets, we demonstrated detection of all commonly reported pathogenic species of Legionellaand were able to differentiate L. pneumophila. Specificity was demonstrated by testing both culture-negative BAL specimens, and an extensive panel of non-Legionellabacterial isolates. Sensitivity was 100% in clinical specimens, and additional spiking studies showed detection to <10 CFU ofLegionella organisms. Inhibition of LC-PCR was minimal, as demonstrated with artificially spiked extracts of Legionellaculture-negative BAL specimens. The entire LightCycler assay, including preparation of the BAL specimen, can be easily performed in 1 to 2 h. This compares to the extended incubation periods needed forLegionella cultures. The DFA assay, while requiring a similar time frame for testing, was shown to have a relatively low sensitivity (33%). While a wide range of sensitivities for this assay has been reported (20), the lower number is consistent with the findings of some investigators (11, 12). The DFA assay performed better in paraffin-embedded tissue sections than in BAL specimens. Our results for sensitivity (44%) are slightly lower than those reported by Theaker et al. (51) (six of nine positives detected) and higher that those noted by Koide et al. (29) (two of eight positives detected). In comparison, for the current study examination of WS-stained slides demonstrated a sensitivity of 63%, which is similar to the results obtained in an earlier study using the Dieterle silver impregnation method (4).

We are aware of a single report evaluating the ISH method (16). This investigation showed ISH to have a sensitivity of 69%, compared to other methods (culture, DFA assays, and serology), for the identification of Legionella in fixed tissue specimens (16). The present study demonstrated that both real-time PCR and ISH were able to detect a majority of cases of legionellosis. ISH, in this case limited to the detection of L. pneumophila, was positive in all specimens infected by that species (100% sensitivity). This method has a rapid turnaround time (roughly 24 h, including tissue processing—same day, excluding tissue processing). The LC-PCR Legionella genus assay had a sensitivity of 69% and a specificity 100%; the assay was able to detect the single patient infected by L. bozemanii. In contrast, the mip L. pneumophila species-specific PCR assay performed poorly with tissue sections, with a sensitivity of only 17%.

The lower sensitivity of LC-PCR with tissue specimens, compared to that with BAL specimens, may be explained by several factors. Inhibition of the PCR, either by components of the extraction process, or by substances in tissue specimens, may have played a role. We noted that in the initial 50 μl of eluant from the extraction column, there was significant inhibition of PCR. Inhibition was minimal in the second eluant, suggesting that an inhibitory compound(s) was either diluted or washed through by that point in the procedure. Consistent with this is the fact that more specimens were positive in the second eluant (nine samples positive) than in the first eluant (six samples positive). Unfortunately, while the inhibitory effect may have been reduced, the second eluant also would have a markedly reduced quantity of target DNA. Overall efficiency of the extraction protocol may also be a factor. Additionally, amplification of DNA from fresh tissue samples versus formalin-fixed samples may have resulted in higher sensitivities. No fresh tissue was available for the current study. Formalin fixation may fragment DNA, making fewer targets of acceptable size available for PCR. Moreover, the higher sensitivity of theLegionella 5S rDNA genus assay versus the L. pneumophila mip species-specific assays may also relate to this effect; smaller amplicons were produced with the Legionella5S rDNA genus assays (105 bp) than with the L. pneumophila mip species-specific assay (124 bp). These factors aside, decreased sensitivity of the mip gene assay compared with the 5S rDNA assay may also be explained by the fact that themip gene is present as a single copy per genome, as opposed to the 5S rDNA sequence, which may present in multiple copies.

Despite some limitations in sensitivity for detectingLegionella species in tissue specimens, LC-PCR appears to be as sensitive as culture for detecting Legionellaspecies in BAL specimens. While the total number of cases in our study was relatively small, the findings are corroborated by those of several other authors, using conventional PCR methods (22, 24, 28, 29, 53); several of these authors showed PCR to have a higher rate of detection than culture-based methods. The use of real-time PCR increases the ease and practicality with which PCR can be introduced into the clinical laboratory. It also offers a dramatic decrease in turnaround time for results and a marked reduction in the risk of carryover contamination (inherent in single-tube amplification assays).

Molecular detection methodologies are particularly useful in the case of slow-growing organisms, such as Legionella species. If these molecular methods are demonstrated to be as sensitive as culture, then culture should not be required to confirm negative molecular test results. If an organism has a predictable antimicrobial susceptibility profile, the need to cultivate the organism may be also obviated. However, if DNA fingerprinting by pulsed-field gel electrophoresis of genomic DNA is required for epidemiological purposes, then the organism must be cultured. As a precaution, one may attempt to culture all specimens which are positive by LC-PCR, with the cultures to be used in the event that further studies (antimicrobial susceptibility or DNA fingerprinting) are needed.

With respect to detection of Legionella in tissue, it is probable that further optimization of extraction methods would increase the sensitivity of LC-PCR. Based on the limited number of specimens included in this study, the ISH method we used was a more accurate means than LC-PCR for detection of L. pneumophila in tissue. ISH offers a faster turnaround time for results than culture. Also of benefit, compared both to culture and to PCR, ISH preserves tissue morphology and requires only a 4-μm-thick tissue section. This might be of particular benefit in the instances in which limited biopsy material is available for culture or for PCR assays. The primary drawback to the ISH assay that we used is that its detection is limited to L. pneumophila; however, the development of additional ISH probes could remedy this problem. Both ISH and PCR offer the advantage over culture of using formalin-fixed tissue. This allows retrospective study when culture results are not available or when fresh tissue is unavailable for culture, either due to quantitative limitations or because Legionella may not have been a diagnostic consideration at the time of biopsy.

The reported sensitivity of L. pneumophila serogroup 1 polysaccharide urinary antigen determination in active cases of disease has ranged from 55 to 90% (8-10, 25, 48, 56). For the present study, the sensitivity of L. pneumophilaspecies-specific LC-PCR was 100%; with open lung biopsies, the sensitivity of L. pneumophila species-specific ISH was 100%. As we did not perform L. pneumophila urinary antigen assays of samples from these patients, we cannot effectively deduce what the sensitivity of the antigen assay would be. Therefore, the utility of urinary antigen assays in our patients is undetermined.

The availability of real-time PCR offers the potential for dramatically increasing the speed with which legionellosis can be diagnosed. PCR appears equal to culture in sensitivity and specificity for BAL specimens. The use of real-time PCR offers advantages over conventional amplification methods, including an easily performed test, procedure, a marked decrease in turnaround time for results, and a reduction in the risk of cross-contamination. These factors should make this technology adaptable for routine use in the clinical laboratory.

While a prospective study is needed to prove the clinical value of the LC-PCR assay described herein, it appears suitable as a first-line assay for the detection of Legionella species in BAL specimens. Samples positive by PCR could be cultured in order to allow for supplemental studies (i.e., epidemiologic investigations or antimicrobial susceptibility testing). In contrast, considering the assays we evaluated, culture was the best method for detectingLegionella species in lung tissue. WS staining,Legionella genus LC-PCR, and L. pneumophila-specific ISH were useful as rapid tests.

ACKNOWLEDGMENT

Roberta Kondert is thanked for her effort in preparing the manuscript.

FOOTNOTES

    • Received 16 November 2000.
    • Returned for modification 11 January 2001.
    • Accepted 22 March 2001.
  • Copyright © 2001 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bej A. K.,
    2. Mahbubani M. H.,
    3. Miller R.,
    4. DiCesare J. L.,
    5. Haff L.,
    6. Atlas R. M.
    Multiplex PCR amplification and immobilized capture probes for detection of bacterial pathogens and indicators in water.Mol. Cell. Probes41990353365
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Benson R. F.,
    2. Fields B. S.
    Classification of the genus Legionella.Semin. Respir. Infect.1319989099
    OpenUrlPubMed
  3. 3.↵
    1. Blackmon J. A.,
    2. Chandler F. W.,
    3. Hicklin M. D.
    Legionnaires' disease: a review for pathologists.Pathol. Annu.141979383404
    OpenUrl
  4. 4.↵
    1. Chandler F. W.,
    2. Hicklin M. D.,
    3. Blackmon J. A.
    Demonstration of the agent of Legionnaires' disease in tissue.N. Engl. J. Med.297197712181220
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Cherry W. B.,
    2. Pittman B.,
    3. Harris P. P.,
    4. Hebert G. A.,
    5. Thomason B. M.,
    6. Thacker L.,
    7. Weaver R. E.
    Detection of Legionnaires disease bacteria by direct immunofluorescent staining.J. Clin. Microbiol.81978329338
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Cloud J. L.,
    2. Carroll K. C.,
    3. Pixton P.,
    4. Erali M.,
    5. Hillyard D. R.
    Detection of Legionella species in respiratory specimens using PCR with sequencing confirmation.J. Clin. Microbiol.38200017091712
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Doern G. V.
    Detection of selected fastidious bacteria.Clin. Infect. Dis.302000166173
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Domı́nguez J. A.,
    2. Galı́ N.,
    3. Pedroso P.,
    4. Fargas A.,
    5. Padilla E.,
    6. Manterola J. M.,
    7. Matas L.
    Comparison of the Binax Legionella urinary antigen enzyme immunoassay (EIA) with the Biotest Legionella Urin Antigen EIA for detection of Legionella antigen in both concentrated and nonconcentrated urine samples.J. Clin. Microbiol.36199827182722
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Dominguez J. A.,
    2. Manterola J. M.,
    3. Blavia R.,
    4. Sopena N.,
    5. Belda F. J.,
    6. Padilla E.,
    7. Gimenez M.,
    8. Sabria M.,
    9. Morera J.,
    10. Ausina V.
    Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration.J. Clin. Microbiol.34199623342336
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Dominguez J. A.,
    2. Matas L.,
    3. Manterola J. M.,
    4. Blavia R.,
    5. Sopena N.,
    6. Belda F. J.,
    7. Padilla E.,
    8. Gimenez M.,
    9. Sabria M.,
    10. Morera J.,
    11. Ausina V.
    Comparison of radioimmunoassay and enzyme immunoassay kits for detection of Legionella pneumophila serogroup 1 antigen in both concentrated and nonconcentrated urine samples.J. Clin. Microbiol.35199716271629
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Edelstein P. H.
    The laboratory diagnosis of Legionnaires' disease.Semin. Respir. Infect.21987235241
    OpenUrlPubMed
  12. 12.↵
    1. Edelstein P. H.,
    2. Beer K. B.,
    3. Sturge J. C.,
    4. Watson A. J.,
    5. Goldstein L. C.
    Clinical utility of a monoclonal direct fluorescent reagent specific for Legionella pneumophila: comparative study with other reagents.J. Clin. Microbiol.221985419421
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Edelstein P. H.,
    2. Bryan R. N.,
    3. Enns R. K.,
    4. Kohne D. E.,
    5. Kacian D. L.
    Retrospective study of Gen-Probe rapid diagnostic system for detection of legionellae in frozen clinical respiratory tract samples.J. Clin. Microbiol.25198710221026
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Engleberg N. C.,
    2. Carter C.,
    3. Demarsh P.,
    4. Drutz D. J.,
    5. Eisenstein B. I.
    A Legionella-specific DNA probe detects organisms in lung tissue homogenates from intranasally inoculated mice.Isr. J. Med. Sci.221986703705
    OpenUrlPubMed
  15. 15.↵
    1. Espy M. J.,
    2. Uhl J. R.,
    3. Mitchell P. S.,
    4. Thorvilson J. N.,
    5. Svien K. A.,
    6. Wold A. D.,
    7. Smith T. F.
    Diagnosis of herpes simplex virus infections in the clinical laboratory by LightCycler PCR.J. Clin. Microbiol.382000795799
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Fain J. S.,
    2. Bryan R. N.,
    3. Cheng L.,
    4. Lewin K. J.,
    5. Porter D. D.,
    6. Grody W. W.
    Rapid diagnosis of Legionella infection by a nonisotopic in situ hybridization method.Am. J. Clin. Pathol.951991719724
    OpenUrlPubMed
  17. 17.↵
    1. Fang G. D.,
    2. Yu V. L.,
    3. Vickers R. M.
    Disease due to the Legionellaceae (other than Legionella pneumophila). Historical, microbiological, clinical, and epidemiological review.Medicine (Baltimore)681989116132 (Erratum, 68:209.)
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    1. Finkelstein R.,
    2. Brown P.,
    3. Palutke W. A.,
    4. Wentworth B. B.,
    5. Geiger J. G.,
    6. Bostic G. D.,
    7. Sobel J. D.
    Diagnostic efficacy of a DNA probe in pneumonia caused by Legionella species.J. Med. Microbiol.381993183186
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Grimm D.,
    2. Merkert H.,
    3. Ludwig W.,
    4. Schleifer K. H.,
    5. Hacker J.,
    6. Brand B. C.
    Specific detection of Legionella pneumophila: construction of a new 16S rRNA-targeted oligonucleotide probe.Appl. Environ. Microbiol.64199826862690
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Grimont P. A.
    Rapid methods for identification of Legionella—a review.Isr. J. Med. Sci.221986697702
    OpenUrlPubMed
  21. 21.↵
    1. Helbig J. H.,
    2. Kurtz J. B.,
    3. Pastoris M. C.,
    4. Pelaz C.,
    5. Luck P. C.
    Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups.J. Clin. Microbiol.35199728412845
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Jaulhac B.,
    2. Nowicki M.,
    3. Bornstein N.,
    4. Meunier O.,
    5. Prevost G.,
    6. Piemont Y.,
    7. Fleurette J.,
    8. Monteil H.
    Detection of Legionella spp. in bronchoalveolar lavage fluids by DNA amplification.J. Clin. Microbiol.301992920924
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Johnson J. L.
    Similarity analysis of rRNAs Methods for general and molecular bacteriology. Gerhardt P., Murray R. G. E., Wood W. A., Krieg N. R. 1994 683 700 American Society for Microbiology Washington, D.C.
  24. 24.↵
    1. Jonas D.,
    2. Rosenbaum A.,
    3. Weyrich S.,
    4. Bhakdi S.
    Enzyme-linked immunoassay for detection of PCR-amplified DNA of legionellae in bronchoalveolar fluid.J. Clin. Microbiol.33199512471252
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    1. Kashuba A. D.,
    2. Ballow C. H.
    Legionella urinary antigen testing: potential impact on diagnosis and antibiotic therapy.Diagn. Microbiol. Infect. Dis.241996129139
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Ke D.,
    2. Menard C.,
    3. Picard F. J.,
    4. Boissinot M.,
    5. Ouellette M.,
    6. Roy P. H.,
    7. Bergeron M. G.
    Development of conventional and real-time PCR assays for the rapid detection of group B streptococci.Clin. Chem.462000324331
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Kessler H. H.,
    2. Reinthaler F. F.,
    3. Pschaid A.,
    4. Pierer K.,
    5. Kleinhappl B.,
    6. Eber E.,
    7. Marth E.
    Rapid detection of Legionella species in bronchoalveolar lavage fluids with the EnviroAmp Legionella PCR amplification and detection kit.J. Clin. Microbiol.31199333253328
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Koide M.,
    2. Saito A.
    Diagnosis of Legionella pneumophila infection by polymerase chain reaction.Clin. Infect. Dis.211995199201
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Koide M.,
    2. Saito A.,
    3. Kusano N.,
    4. Tateyama M.,
    5. Inadome J.,
    6. Kyan Y.,
    7. Kishaba T.,
    8. Miyagi S.
    Relation between the polymerase chain reaction and the indirect fluorescent antibody method in the diagnosis of Legionella infection.Clin. Infect. Dis.231996656657
    OpenUrlCrossRefPubMed
  30. 30.
    Koneman, E. W., S. D. Allen, W. M. Janda, P. C. Schreckenberger, and W. C. Winn (ed.). Color atlas and textbook of diagnostic microbiology. 5th ed., p. 473–489. Lippincott-Raven Publishers, Philadelphia, Pa.
  31. 31.↵
    1. Lee M. A.,
    2. Brightwell G.,
    3. Leslie D.,
    4. Bird H.,
    5. Hamilton A.
    Fluorescent detection techniques for real-time multiplex strand specific detection of Bacillus anthracis using rapid PCR.J. Appl. Microbiol.871999218223
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Lindsay D. S.,
    2. Abraham W. H.,
    3. Fallon R. J.
    Detection of mip gene by PCR for diagnosis of Legionnaires' disease.J. Clin. Microbiol.32199430683069
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Lisby G.,
    2. Dessau R.
    Construction of a DNA amplification assay for detection of Legionella species in clinical samples.Eur. J. Clin. Microbiol. Infect. Dis.131994225231
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Lloyd R. V.,
    2. Jin L.
    In situ hybridization analysis of chromogranin A and B mRNAs in neuroendocrine tumors with digoxigenin-labeled oligonucleotide probe cocktails.Diagn. Mol. Pathol.41995143151
    OpenUrlPubMed
  35. 35.↵
    1. Mahbubani M. H.,
    2. Bej A. K.,
    3. Miller R.,
    4. Haff L.,
    5. DiCesare J.,
    6. Atlas R. M.
    Detection of Legionella with polymerase chain reaction and gene probe methods.Mol. Cell. Probes41990175187
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Maiwald M.,
    2. Schill M.,
    3. Stockinger C.,
    4. Helbig J. H.,
    5. Luck P. C.,
    6. Witzleb W.,
    7. Sonntag H. G.
    Detection of Legionella DNA in human and guinea pig urine samples by the polymerase chain reaction.Eur. J. Clin. Microbiol. Infect. Dis.1419952533
    OpenUrlCrossRefPubMedWeb of Science
  37. 37.↵
    1. Matsiota-Bernard P.,
    2. Pitsouni E.,
    3. Legakis N.,
    4. Nauciel C.
    Evaluation of commercial amplification kit for detection of Legionella pneumophila in clinical specimens.J. Clin. Microbiol.32199415031505
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Menendez R.,
    2. Cordoba J.,
    3. de La Cuadra P.,
    4. Cremades M. J.,
    5. Lopez-Hontagas J. L.,
    6. Salavert M.,
    7. Gobernado M.
    Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia.Am. J. Respir. Crit. Care Med.159199918681873
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. Mikel U. V.
    Advanced laboratory methods in histology and pathology. 1994 American Registry of Pathology Washington, D.C.
  40. 40.↵
    1. Miyamoto H.,
    2. Yamamoto H.,
    3. Arima K.,
    4. Fujii J.,
    5. Maruta K.,
    6. Izu K.,
    7. Shiomori T.,
    8. Yoshida S.
    Development of a new seminested PCR method for detection of Legionella species and its application to surveillance of legionellae in hospital cooling tower water.Appl. Environ. Microbiol.63199724892494
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Munder R. U.
    Other Legionella Species Principles and practice of infectious diseases 5th ed. Mandell G. L., Bennett J. E., Dolin R. 2 2000 2435 2441 Churchill Livingstone Philadelphia, Pa
    OpenUrl
  42. 42.↵
    1. Murdoch D. R.,
    2. Walford E. J.,
    3. Jennings L. C.,
    4. Light G. J.,
    5. Schousboe M. I.,
    6. Chereshsky A. Y.,
    7. Chambers S. T.,
    8. Town G. I.
    Use of the polymerase chain reaction to detect Legionella DNA in urine and serum samples from patients with pneumonia.Clin. Infect. Dis.231996475480
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Murray P. R.,
    2. Baron E. J.,
    3. Pfaller M. A.,
    4. Tenover F. C.,
    5. Yolken R. H.
    Manual of clinical microbiology 5th ed. 1999 ASM Press Washington, D.C.
  44. 44.↵
    1. Nitsche A.,
    2. Steuer N.,
    3. Schmidt C. A.,
    4. Landt O.,
    5. Siegert W.
    Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA.Clin. Chem.45199919321937
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Pasculle A. W.,
    2. Veto G. E.,
    3. Krystofiak S.,
    4. McKelvey K.,
    5. Vrsalovic K.
    Laboratory and clinical evaluation of a commercial DNA probe for the detection of Legionella spp.J. Clin. Microbiol.27198923502358
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Ramirez J. A.,
    2. Ahkee S.,
    3. Tolentino A.,
    4. Miller R. D.,
    5. Summersgill J. T.
    Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen.Diagn. Microbiol. Infect. Dis.241996714
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    1. Reingold A. L.,
    2. Thomason B. M.,
    3. Brake B. J.,
    4. Thacker L.,
    5. Wilkinson H. W.,
    6. Kuritsky J. N.
    Legionella pneumonia in the United States: the distribution of serogroups and species causing human illness.J. Infect. Dis.1491984819
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Sathapatayavongs B.,
    2. Kohler R. B.,
    3. Wheat L. J.,
    4. White A.,
    5. Winn W. C. Jr.
    Rapid diagnosis of Legionnaires' disease by latex agglutination.Am. Rev. Respir. Dis.1271983559562
    OpenUrlPubMedWeb of Science
  49. 49.↵
    1. Starnbach M. N.,
    2. Falkow S.,
    3. Tompkins L. S.
    Species-specific detection of Legionella pneumophila in water by DNA amplification and hybridization.J. Clin. Microbiol.27198912571261
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Suffin S. C.,
    2. Kaufmann A. F.,
    3. Whitaker B.,
    4. Muck K. B.,
    5. Prince G. A.,
    6. Porter D. D.
    Legionella pneumophila: identification in tissue sections by a new immunoenzymatic procedure.Arch. Pathol. Lab. Med.1041980283286
    OpenUrlPubMed
  51. 51.↵
    1. Theaker J. M.,
    2. Tobin J. O.,
    3. Jones S. E.,
    4. Kirkpatrick P.,
    5. Vina M. I.,
    6. Fleming K. A.
    Immunohistological detection of Legionella pneumophila in lung sections.J. Clin. Pathol.401987143146
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. Thomason B. M.,
    2. Van Orden A.,
    3. Chandler F. W.,
    4. Hicklin M. D.
    Effect of various histological fixatives on fluorescent antibody detection of Legionnaires disease bacteria.J. Clin. Microbiol.101979106108
    OpenUrlAbstract/FREE Full Text
  53. 53.↵
    1. Weir S. C.,
    2. Fischer S. H.,
    3. Stock F.,
    4. Gill V. J.
    Detection of Legionella by PCR in respiratory specimens using a commercially available kit.Am. J. Clin. Pathol.1101998295300
    OpenUrlPubMedWeb of Science
  54. 54.↵
    1. Whitcombe D.,
    2. Newton C. R.,
    3. Little S.
    Advances in approaches to DNA-based diagnostics.Curr. Opin. Biotechnol.91998602608
    OpenUrlCrossRefPubMedWeb of Science
  55. 55.↵
    1. Wilkinson H. W.,
    2. Sampson J. S.,
    3. Plikaytis B. B.
    Evaluation of a commercial gene probe for identification of Legionella cultures.J. Clin. Microbiol.231986217220
    OpenUrlAbstract/FREE Full Text
  56. 56.↵
    1. Winn W. C.
    Legionella Manual of clinical microbiology. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. 1999 572 585 ASM Press Washington, D.C.
  57. 57.↵
    1. Wittwer C. T.,
    2. Herrmann M. G.,
    3. Moss A. A.,
    4. Rasmussen R. P.
    Continuous fluorescence monitoring of rapid cycle DNA amplification.BioTechniques221997130131, 134–138.
    OpenUrlCrossRefPubMedWeb of Science
  58. 58.↵
    1. Wittwer C. T.,
    2. Ririe K. M.,
    3. Andrew R. V.,
    4. David D. A.,
    5. Gundry R. A.,
    6. Balis U. J.
    The LightCycler: a microvolume multisample fluorimeter with rapid temperature control.BioTechniques221997176181
    OpenUrlCrossRefPubMedWeb of Science
  59. 59.↵
    1. Woo T. H.,
    2. Patel B. K.,
    3. Smythe L. D.,
    4. Symonds M. L.,
    5. Norris M. A.,
    6. Weyant R. S.,
    7. Dohnt M. F.
    Identification of Leptospira inadai by continuous monitoring of fluorescence during rapid cycle PCR.Syst. Appl. Microbiol.2119988996
    OpenUrlPubMed
  60. 60.↵
    1. Yu V. L.
    Legionella pneumophila Principles and practice of infectious diseases 5th ed. Mandell G. L., Bennett J. E., Dolin R. 2 2000 2424 2435 Churchill Livingstone Philadelphia, Pa
    OpenUrl
  61. 61.↵
    1. Zuravleff J. J.,
    2. Yu V. L.,
    3. Shonnard J. W.,
    4. Davis B. K.,
    5. Rihs J. D.
    Diagnosis of Legionnaires' disease. An update of laboratory methods with new emphasis on isolation by culture.JAMA250198319811985
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Direct Detection of Legionella Species from Bronchoalveolar Lavage and Open Lung Biopsy Specimens: Comparison of LightCycler PCR, In Situ Hybridization, Direct Fluorescence Antigen Detection, and Culture
R. T. Hayden, J. R. Uhl, X. Qian, M. K. Hopkins, M. C. Aubry, A. H. Limper, R. V. Lloyd, F. R. Cockerill
Journal of Clinical Microbiology Jul 2001, 39 (7) 2618-2626; DOI: 10.1128/JCM.39.7.2618-2626.2001

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Direct Detection of Legionella Species from Bronchoalveolar Lavage and Open Lung Biopsy Specimens: Comparison of LightCycler PCR, In Situ Hybridization, Direct Fluorescence Antigen Detection, and Culture
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Direct Detection of Legionella Species from Bronchoalveolar Lavage and Open Lung Biopsy Specimens: Comparison of LightCycler PCR, In Situ Hybridization, Direct Fluorescence Antigen Detection, and Culture
R. T. Hayden, J. R. Uhl, X. Qian, M. K. Hopkins, M. C. Aubry, A. H. Limper, R. V. Lloyd, F. R. Cockerill
Journal of Clinical Microbiology Jul 2001, 39 (7) 2618-2626; DOI: 10.1128/JCM.39.7.2618-2626.2001
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

bronchoalveolar lavage fluid
Legionella
Legionellosis
Lung

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X